Nu-Med Plus (NUMD) Depreciation & Amortization (CF) (2012 - 2022)
Nu-Med Plus (NUMD) posted Depreciation & Amortization (CF) of $35.0 for Q3 2022, down 83.87% sequentially from $217.0 in Q2 2022, and down 98.68% YoY from $2650.0 in Q3 2021.
Nu-Med Plus (NUMD) Depreciation & Amortization (CF) (2012 - 2022) Analysis & Trends
Nu-Med Plus has reported Depreciation & Amortization (CF) for 11 years, with the latest figure at $35.0 in Q3 2022.
- Quarterly Depreciation & Amortization (CF) fell 98.68% year-over-year to $35.0 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $35.0 (down 99.54% YoY) and the FY2022 annual result came in at $2267.0, down 75.79% from the prior year.
- Depreciation & Amortization (CF) retreated to $35.0 in Q3 2022 per NUMD's latest filing, from $217.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $3803.0 in Q2 2018 and troughed at $35.0 in Q3 2022.
- A 5-year average of $2712.4 and a median of $3048.0 in 2020 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2018 and 2022: Depreciation & Amortization (CF) jumped 100.62% in 2018, then slumped 98.68% in 2022.
- Over 5 years, Depreciation & Amortization (CF) stood at $3774.0 in 2018, then slipped by 19.55% to $3036.0 in 2019, then dropped by 12.71% to $2650.0 in 2020, then changed by 0.0% to $2650.0 in 2021, then plunged by 98.68% to $35.0 in 2022.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $35.0, $217.0, and $2015.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.75 Bn | 194.14 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.36 Bn | 123.88 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.20 Bn | 72.66 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 35.00 |
| Sep 30, 2022 | 35.00 |
| Jun 30, 2022 | 217.00 |
| Jun 30, 2022 | 217.00 |
| Mar 31, 2022 | 2,015.00 |
| Mar 31, 2022 | 2,015.00 |
| Dec 31, 2021 | 2,650.00 |
| Dec 31, 2021 | 2,650.00 |
| Sep 30, 2021 | 2,650.00 |
| Sep 30, 2021 | 2,650.00 |
| Jun 30, 2021 | 1,416.00 |
| Jun 30, 2021 | 1,416.00 |
| Mar 31, 2021 | 2,649.00 |
| Mar 31, 2021 | 2,649.00 |
| Dec 31, 2020 | 2,650.00 |
| Dec 31, 2020 | 2,650.00 |
| Sep 30, 2020 | 3,048.00 |
| Sep 30, 2020 | 3,048.00 |
| Jun 30, 2020 | 3,048.00 |
| Jun 30, 2020 | 3,048.00 |